Hammond Janet MJ
SEC CIK 1829899 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | Chief Development Off | 141.8K | — | $53.9K | 7 | 2024-01-31 | 2026-01-31 |
Most active insiders at AVIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Murphy Polly A. | Dir | $25.4K | — |
| 2 | Adams Jerome M. | Dir | — | — |
| 3 | Hammond Janet MJ | Chief Development Off | — | — |
| 4 | Vavricka John | Chief Commercial Off | — | — |
| 5 | Lucidi Bruno | Dir | — | — |
| 6 | Horga Maria Arantxa | Chief Medical Off | — | — |
| 7 | Foster Wayne | EVP, CAO | — | — |
| 8 | Polsky Bruce | Dir | — | — |
| 9 | DUNCAN BARBARA GAYLE | Dir | — | — |
| 10 | Corcoran Andrea | See Remarks | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-03 | 2026-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Hammond Janet MJ | Chief Development Off | M - OptEx | — | +58.0K | 141.8K | +69% | — |
| D | 2026-02-03 | 2026-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Hammond Janet MJ | Chief Development Off | F - Tax | $4.24 | -14.1K | 127.7K | -10% | -$59.9K |
| D | 2025-02-04 | 2025-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Hammond Janet MJ | Chief Development Off | M - OptEx | — | +46.8K | 84.3K | +125% | — |
| D | 2025-02-04 | 2025-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Hammond Janet MJ | Chief Development Off | F - Tax | $3.06 | -14.1K | 81.4K | -15% | -$43.3K |
| D | 2025-02-04 | 2025-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Hammond Janet MJ | Chief Development Off | A - Grant | — | +11.2K | 95.5K | +13% | — |
| D | 2024-02-02 | 2024-02-01 | AVIR | Atea Pharmaceuticals, Inc. | Hammond Janet MJ | Chief Development Off | S - Sale+OE | $3.84 | -14.0K | 35.4K | -28% | -$53.9K |
| D | 2024-02-02 | 2024-01-31 | AVIR | Atea Pharmaceuticals, Inc. | Hammond Janet MJ | Chief Development Off | M - OptEx | — | +46.8K | 49.4K | +1,806% | — |
Purchase Sale Sale after option exercise All abbreviations